NORADRENALINE

The United States Food and Drug Administration (FDA) granted initial approval to noradrenaline on 6 April 1948.

Noradrenaline, a vasopressor medication, manages various critical medical situations. It elevates blood pressure in acute hypotension, shock (including septic and cardiogenic shock), and cardiac arrest. Additionally, this medication aids in treating bradycardia and anaphylactic shock and enhancing regional anesthesia.

Noradrenaline is primarily administered intravenously (IV). It's typically given as a continuous infusion through a dedicated IV line under the supervision of trained medical personnel. The IV route allows for precise control of the medication's effects and rapid dosage adjustment in critical situations. This medication requires careful monitoring of vital signs and the patient's response to ensure its safety and efficacy.

Noradrenaline use can lead to a range of potential side effects. Common effects include increased heart rate, elevated blood pressure, headaches, nervousness, nausea, and pale skin. Serious adverse reactions encompass hypertensive crises, arrhythmias, tissue ischemia, and possible extravasation at the infusion site.

Rapid or excessive administration of Noradrenaline can lead to a dangerous increase in blood pressure, potentially causing hypertensive crisis, which can result in stroke, heart attack, or other cardiovascular complications. The vasoconstrictive effects of this medication can reduce blood flow to organs or extremities, leading to tissue ischemia or damage. Incorrect IV insertion or monitoring can result in extravasation, where this medication leaks from the IV site into surrounding tissues, causing severe local tissue damage. Its effects on pulmonary blood vessels can lead to increased pulmonary artery pressure, potentially worsening lung conditions.

Noradrenalin administration should be slow to avoid sudden spikes in blood pressure that can be harmful. Keep an eye on the heart rhythm to catch any irregularities early on. Be careful with the dosage, as too much can reduce blood flow to important areas. If someone has lung problems, be extra cautious, as this medication can affect their condition. Dose adjustment is required for different groups, like children and the elderly, as they may need different amounts. Avoid mixing this medication with certain medicines, like nonselective MAOIs, to prevent serious problems. If someone is pregnant, carefully weigh the risks and benefits with a healthcare provider. These precautions are like safety guidelines that help prevent complications and ensure they work well for patients.

Close monitoring by healthcare professionals is essential during noradrenaline therapy. Dose adjustment may be necessary based on the patient's age and individual response to treatment. Regular assessment of heart rate, blood pressure, and systemic response is required throughout administration. Patients should be alert to potentially serious adverse effects, including hypertension and cardiac arrhythmias. Careful attention to intravenous line placement is necessary to prevent extravasation. Patients must report any side effects or difficulties encountered during treatment to their healthcare provider.

Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Adrenergic agonists and antagonists, 12th edition, 2011, 287. KD Tripathi, Essentials of Medical Pharmacology, Adrenergic system and drugs, 7th edition, 2013, 133. Hospira UK Limited, Electronic medicines compendium (EMC), [Revised on 18 Aug 2022] [Accessed on 14th August 2023], https://www.medicines.org.uk/emc/product/4115/pil Baxter Healthcare Corporation, US Food and Drug Administration, [Revised on Jan 2021] [Accessed on 14th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214313s000lbl.pdf